Change in ARCC Co-Directorship effective December 1, 2015

Thank you Dr. Jeffrey Hoch

In November 2015, Dr. Jeffrey Hoch stepped down from his role as Co-Director of the Canadian Centre for Applied Research in Cancer Control (ARCC). Dr. Hoch is an original ARCC Co-Founder, and has helped lead ARCC since 2009. During that time the ARCC Network has grown to almost 700 people, and ARCC has undertaken over 40 research projects, supported numerous trainees, and hosted four national conferences. His leadership has been central to the many successes the Centre has been involved with, and Jeff continues to be internationally recognized for his leadership in applied cancer research.

We wish Dr. Hoch every success as he assumes his new positions as Professor in the Department of Health Sciences at the University of California at Davis (UCD) and Associate Director of UCD’s Center for Health Policy and Research (CHPR).

Dr. Hoch is proud of what ARCC has accomplished, “My time with ARCC has been remarkable, both professionally and personally rewarding in so many ways. It has been full of exciting opportunities to meet and collaborate with passionate professionals as well as young people looking to define their own careers. Our dedicated staff and partners continue to inspire my work, and I will always feel a sense of pride regarding ARCC’s accomplishments. I want to thank Stuart Peacock, our centre support staff, our investigators, associates, and members for the privilege of working with this extraordinary organization over the past six years. I also want to thank the Canadian Cancer Society Research Institute and our other partners for their generous support of the work that we do. ARCC is truly a special organization that continues to improve the spectrum of cancer control within Canada.” Dr. Hoch will continue to support ARCC in a senior advisory role.

Dr. Hoch leaves behind a strong and lasting legacy in Canada. Please join us in thanking him for his dedication to our organization, and in wishing him continued success in his new career.


Welcome Dr. Kelvin Chan

It is with great pleasure that ARCC welcomes Dr. Kelvin Chan who has joined us in the role of Co-Director and Health Technology Assessment program lead effective December 1, 2015. Kelvin is a Medical Oncologist with the Sunnybrook Health Sciences Centre, and a Clinical Lead within the Provincial Drug Reimbursement Program at Cancer Care Ontario. He also holds an appointment as an Assistant Professor with the Department of Medicine at the University of Toronto. His research interests include health technology and drug assessments, economic evaluations, and drug funding and reimbursement issues. He is a member of the pCODR Expert Review Committee (pERC), Ontario’s Committee to Evaluate Drugs (CED), and the Ontario Steering Committee of Cancer Drugs (OSCCD). We are especially excited to work with Kelvin who brings a wealth of clinical and research experience with him to ARCC.

“I am really excited to join the leadership team at ARCC, and help continue to build and enhance the ARCC research network in support of improving the continuum of cancer care in Canada.”

Please join us in welcoming Kelvin to the ARCC team!

All the best, Stuart and the ARCC team

Dr. Stuart Peacock

Leslie Diamond Chair in Cancer Survivorship
Faculty of Health Sciences, Simon Fraser University

Canadian Centre for Applied Research in Cancer Control (ARCC)

Distinguished Scientist
Cancer Control Research, British Columbia Cancer Agency

Canadian Centre for Applied Research in Cancer Control (ARCC)
2nd floor, BC Cancer Research Centre, 675 West 10th Avenue,
Vancouver, BC, V5Z 1L3, Canada.
Tel 604 675 8068;


ARCC is funded by the Canadian Cancer Society

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply